Vibe Bio provides expert-guided AI analytics through its VibeOne platform, helping biopharma business development and in-licensing teams source, evaluate, prioritize, track, and conduct diligence on therapeutic assets. The platform aggregates scientific, clinical, commercial, and market data, applies AI analysis, and produces strategic reports to support faster and more defensible go/no-go decisions. Vibe Bio also invests in early-stage biotech companies developing high-potential therapies and platform technologies, offering portfolio companies strategic insights, network access, and operational support.
